Cengiz Yenikaya

Cengiz Yenikaya

Auto-generated profile, based on publicly available information

Cengiz Yenikaya

Kutahya Dumlupinar Universitesi

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in Polyhedron
Verified
Journal Article
Closed access
CYCengiz Yenikaya
Cengiz Yenikaya
MPMehmet Poyraz
Mehmet Poyraz
MSMusa Sarı
Musa Sarı
FDfatih demirci
fatih demirci
HIHalil İlkimen
Halil İlkimen
OBOrhan Büyükgüngör
Orhan Büyükgüngör

1 October 2013 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
HIHalil İlKimen
Halil İlKimen
CYCengiz Yenikaya
Cengiz Yenikaya
MSMusa Sarı
Musa Sarı
MBMetin Bülbül
Metin Bülbül
MAMelike Aslan
Melike Aslan
YSYasemin Süzen
Yasemin Süzen
A novel proton transfer compound (HMeOABT) + (HDPC)− (1) and its Fe(III), Co(II), Ni(II) and Cu(II) complexes (2–5) have been prepared and characterized by spectroscopic techniques. Complex 4 has distorted octahedral conformation revealed by single crystal X-ray diffraction method. Structures of the other complexes might be proposed as octahedral according to experimental data. All compounds were also evaluated for their in vitro inhibition effects on hCA I and II for their hydratase and esterase activities. Although there is no inhibition for hydratase activities, all compounds have inhibited the esterase activities of hCA I and II. Data have been analyzed by using a one-way analysis of variance. The comparison of the inhibition studies of 1–5 to parent compounds indicates that 1–5 have superior inhibitory effects. The inhibition effects of 2–5 are also compared to inhibitory properties of the metal complexes of MeOABT and H2DPC, revealing an improved transfection profile.

17 September 2018 in Journal of Coordination Chemistry
Verified
Journal Article
Closed access
HIHalil Ilkimen
Halil Ilkimen
YTYasemin Tekşen
Yasemin Tekşen
CYCengiz Yenikaya
Cengiz Yenikaya
ITIrem Turhan
Irem Turhan
TTTuncay Tunç
Tuncay Tunç
MSMusa Sari
Musa Sari
Two proton transfer compounds, formed between 2-aminobenzothiazole derivatives (2-aminobenzothiazole (abt) and 2-amino-6-ethoxybenzothiazole (EtOabt)) and 5-sulfosalicylic acid dihydrate (H3ssa) as parent compounds, (Habt)+(H2ssa)− (1) and (HEtOabt)+(H2ssa)− (2) and their Cu(II) complexes (3 and 4, respectively) have been prepared and characterized using spectroscopic techniques. The single crystal X-ray diffraction method has been also applied to 3 and 4. Although 3 has a distorted octahedral form, 4 exhibits a distorted square pyramidal geometry. All compounds, including saline and diclofenac sodium as standards, have been evaluated pharmacologically for their anti-inflammatory and analgesic activities in rats and mice. Parent compounds (abt, EtOabt, and H3ssa) 3 and 4 show significant anti-inflammatory and analgesic activities as compared with control compounds. Graphical Abstract

1 January 2017 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
ZAZeynep Alkan Alkaya
Zeynep Alkan Alkaya
HIHalil İlkimen
Halil İlkimen
CYCengiz Yenikaya
Cengiz Yenikaya
YKYasemin Kaygısız
Yasemin Kaygısız
MBMetin Bülbül
Metin Bülbül
MSMusa Sarı
Musa Sarı
A novel proton transfer compound (SMHABT)+(HDPC)− (1) obtained from 2-amino-6-sulfamoylbenzothiazole (SMABT) and 2,6-pyridinedicarboxylic acid (H2DPC) and its Fe(III), Co(II), Ni(II) complexes (2–4), and Fe(II) complex of SMABT (5) have been prepared and characterized by spectroscopic techniques. Additionally, single crystal X-ray diffraction techniques were applied to complexes (2–4). All complexes (2–4) have distorted octahedral conformations and the structure of 5 might be proposed as octahedral according to spectral and analytical results. All compounds, including acetazolamide (AAZ) as the control compound, were also evaluated for their in vitro inhibition effects on human hCA I and hCA II for their hydratase and esterase activities. The synthesized compounds have remarkable inhibitory activities on hCA I and hCA II. Especially, the inhibition potentials of the salt and the metal complexes (1–5) are comparable with AAZ. Inhibition data have been analyzed by using a one-way analysis of variance for multiple comparisons (p < .0001).

30 October 2023 in Selçuk Üniversitesi Fen Fakültesi Fen Dergisi
Verified
Journal Article
Open access
PDF file
HIHalil İlki̇men
Halil İlki̇men
CYCengiz Yeni̇kaya
Cengiz Yeni̇kaya
AGAysel Gülbandılar
Aysel Gülbandılar
Bu çalışmada, 2-metoksi-5-sülfamoyilbenzoik asit (Hsba) ile 2-aminopiridin (ap), 2-benzilaminopiridin (2Bzap), 2-aminometilpiridin (2amp) ve 2-amino-3-hidroksipiridin (2a3OHp)’in proton transfer tuzları (2apsba, 2Bzapsba, 2ampsba ve 2a3OHpsba) sentezlenmiştir. Başlangıç maddeleri ve proton transfer tuzlarının Enterococcus faecalis (ATCC 29212), Listeria monocytogenes (ATCC 7644), Bacillus subtilis, Staphylococcus aureus (NRRL-B 767) (Gram pozitif), Escherichia coli (ATCC 25922) ve Pseudomonas aeruginosa (ATCC 27853) (Gram negatif) bakterilerine ve Candida Albicans (ATCC 14053) mayasına karşı antibakteriyel ve antifungal aktiviteleri incelenmiştir. Antifungal aktiviteler Flukonazol ile antibakteriyel aktiviteleri ise Sefepim, Vankomisin ve Levofloksasin ile kıyaslanmıştır. Deneyde kullanılan ve sentezlenen bileşikler bakteri ve mayalara karşı aktiviteye sahiptir. Bileşiklerin en iyi aktivite değerleri B. subtilis bakterisinde 2Bzap ve 2a3OHp (31,25 µg/mL), E. faecalis ve S. aureus bakterilerinde tüm bileşikler (Hsba hariç) (62,50 µg/mL), E. coli bakterisinde 2a3OHpsba (15,60 µg/mL), L. monocytogenes bakterisinde Hsba, 2Bzap, 2amp ve 2a3OHp (31,25 µg/mL), P. aeruginoa bakterisinde Hsba (31,25 µg/mL) ve C. albicans mayasında 2Bzap (31,25 µg/mL)’de gözlenmiştir.

29 March 2023 in Journal of Scientific Reports-A
Verified
Journal Article
Open access
PDF file
HIHalil İlKi̇mEn
Halil İlKi̇mEn
CYCengiz Yeni̇kAya
Cengiz Yeni̇kAya
AGAysel Gülbandılar
Aysel Gülbandılar
In this study, proton transfer salts {(Hap)+(samal)- (4) and (HBI)+(samal)- (5)} were synthesized from the reaction of (E)-3-(4-sulfamoylphenylcarbamoyl)acrylic acid (Hsamal, 1) with 1H-benzimidazole (BI, 3) or 2-aminopyridine (ap, 2), metal complexes of 1 {Fe(II) {[Fe(samal)(H2O)2][Fe(OH)3(H2O)] (6) and [(H2O)(OH)2Fe(samal)Fe(H2O)2] (7)}, Co(II) {[(H2O)(OH)2Co(samal)Co(H2O)2] (8)}, Ni(II) {[Ni(samal)2(H2O)2] (9)} and Cu(II) {[Cu(samal)2(H2O)2] (10)}}, of 4 {Ni(II) {[(H2O)(OH)Ni(samal)Ni(OH)2(ap)(H2O)2] (11)}, Cu(II) {[Cu(samal)(OH)(ap)2] (12)} and of 5 {Co(II) {[(HO)2Co(samal)Co(BI)2] (13)}, Ni(II) {[(H2O)2(HO)3Ni(samal)Ni(BI)2] (14)} and Cu(II) {[(H2O)2(HO)3Cu(samal)Cu(BI)2(OH)] (15)}} by the methods found in the literature. Antimicrobial activities of 1-15 and metal salts {iron(II) sulfate heptahydrate (16), cobalt(II) acetate tetrahydrate (17), nickel(II) acetate tetrahydrate (18) and copper(II) acetate dihydrate (19)} against Enterococcus faecalis (ATCC 29212) (Gram positive), Pseudomonas aeruginosa (ATCC 27853), Bacillus subtilis (wild type), Staphylococcus aureus (NRRL B-767), Listeria monocytogenes (ATCC 7644), Escherichia coli (ATCC 25922) (Gram negative) and Candida albicans (ATCC 14053) (yeast) microorganisms has been tested. The MIC (Minimum Inhibitory Concentration) values of 1-19 were compared with those of reference antimicrobial compounds Vancomycin, Cefepime, Levofloxacin and Fluconazole. Compounds with the best activity are 12 (15.60 µg/mL) for C. albicans, 1 and 2 (31.25 µg/mL) for B. subtilis, 13 (31.25 µg/mL) for E. faecalis, 13 (15.60 µg/mL) for S. aureus, 4 and 12 (15.60 µg/mL) for E. Coli, 3 and 8-12 (31.25 µg/mL) for L. monocytogens, and 8 (31.25 µg/mL) for P. aeruginoa.